200,000+ products from a single source!
sales@angenechem.com
Home > Quinoline > 861877-38-5
861877-38-5 | N-(5-tert-butylisoxazol-3-yl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide
CAS No: 861877-38-5 Catalog No: AG00H3EK MDL No:
Product Description
Catalog Number:
AG00H3EK
Chemical Name:
N-(5-tert-butylisoxazol-3-yl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide
CAS Number:
861877-38-5
IUPAC Name:
N-(5-tert-butyl-1,2-oxazol-3-yl)-6-(6,7-dimethoxyquinolin-4-yl)oxynaphthalene-1-carboxamide
InChI:
InChI=1S/C29H27N3O5/c1-29(2,3)26-16-27(32-37-26)31-28(33)20-8-6-7-17-13-18(9-10-19(17)20)36-23-11-12-30-22-15-25(35-5)24(34-4)14-21(22)23/h6-16H,1-5H3,(H,31,32,33)
InChI Key:
ZWQPZFHCKLZVGB-UHFFFAOYSA-N
Properties
Complexity:
775
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
497.195g/mol
Formal Charge:
0
Heavy Atom Count:
37
Hydrogen Bond Acceptor Count:
7
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
497.551g/mol
Monoisotopic Mass:
497.195g/mol
Rotatable Bond Count:
7
Topological Polar Surface Area:
95.7A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
6.2
Literature
| Title | Journal |
|---|---|
| Molecular modeling studies of vascular endothelial growth factor receptor tyrosine kinase inhibitors using QSAR and docking. | Journal of molecular graphics & modelling 20090101 |
| Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: design, synthesis, and evaluation. | Journal of medicinal chemistry 20080327 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.